$2.57 Billion is the total value of Boxer Capital, LLC's 71 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 35.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc. | $293,380,000 | -17.1% | 2,000,000 | 0.0% | 11.39% | -7.8% | |
| XBI | New | SPDR SER TRs&p biotech | $246,312,000 | – | 2,200,000 | +100.0% | 9.57% | – |
| ITOS | iTeos Therapeutics Inc. | $202,304,000 | +72.4% | 4,345,016 | 0.0% | 7.86% | +91.8% | |
| BGNE | Sell | BeiGene Ltdsponsored adr | $135,465,000 | -51.2% | 500,000 | -34.6% | 5.26% | -45.7% |
| SWTX | Springworks Therapeutics Inc. | $128,665,000 | -2.3% | 2,075,905 | 0.0% | 5.00% | +8.7% | |
| CYTK | Cytokinetics Inc. | $95,718,000 | +27.5% | 2,100,000 | 0.0% | 3.72% | +41.9% | |
| Buy | Tyra Biosciences Inc | $90,728,000 | -18.4% | 6,448,359 | +2.0% | 3.52% | -9.3% | |
| RVMD | Revolution Medicines Inc. | $87,699,000 | -8.5% | 3,484,264 | 0.0% | 3.41% | +1.8% | |
| RLAY | Buy | Relay Therapeutics Inc. | $81,969,000 | +100.9% | 2,669,132 | +106.2% | 3.18% | +123.4% |
| Tango Therapeutics inc | $75,176,000 | -15.4% | 6,871,642 | 0.0% | 2.92% | -5.9% | ||
| PMVP | Buy | PMV Pharmaceuticals Inc. | $65,563,000 | -3.0% | 2,838,236 | +25.1% | 2.55% | +7.9% |
| New | SPDR SER TRcall | $61,578,000 | – | 550,000 | +100.0% | 2.39% | – | |
| MRUS | Merus NV | $60,420,000 | +44.5% | 1,900,000 | 0.0% | 2.35% | +60.8% | |
| RCUS | Sell | Arcus Biosciences Inc. | $57,961,000 | -20.3% | 1,432,200 | -31.3% | 2.25% | -11.3% |
| BPMC | Buy | Blueprint Medicines Corp | $54,345,000 | +24.4% | 507,374 | +19.4% | 2.11% | +38.3% |
| IDYA | Ideaya Biosciences Inc. | $52,074,000 | -7.3% | 2,202,812 | 0.0% | 2.02% | +3.1% | |
| SAGE | Sage Therapeutics Inc. | $46,539,000 | -4.0% | 1,094,000 | 0.0% | 1.81% | +6.8% | |
| ANAB | Anaptys Bio Inc. | $45,175,000 | +28.1% | 1,300,000 | 0.0% | 1.76% | +42.6% | |
| NUVB | Nuvation Bio Inc. | $36,899,000 | -14.5% | 4,341,009 | 0.0% | 1.43% | -4.9% | |
| NRIX | Nurix Therapeutics Inc. | $35,461,000 | -3.4% | 1,224,892 | 0.0% | 1.38% | +7.4% | |
| KNTE | Kinnate Biopharma Inc. | $32,739,000 | -23.0% | 1,847,559 | 0.0% | 1.27% | -14.3% | |
| RCKT | Rocket Pharmaceuticals Inc. | $32,004,000 | -27.0% | 1,466,051 | 0.0% | 1.24% | -18.8% | |
| FATE | New | Fate Therapeutics Inc. | $29,255,000 | – | 500,000 | +100.0% | 1.14% | – |
| GOSS | Gossamer Bio Inc. | $27,849,000 | -10.0% | 2,462,358 | 0.0% | 1.08% | +0.1% | |
| FOLD | Amicus Therapeutics Inc. | $26,854,000 | +20.9% | 2,325,000 | 0.0% | 1.04% | +34.6% | |
| RNA | Avidity Biosciences Inc. | $26,654,000 | -3.5% | 1,121,327 | 0.0% | 1.04% | +7.4% | |
| BLU | Buy | Bellus Health Inc. | $25,760,000 | +41.0% | 3,200,000 | +7.6% | 1.00% | +56.7% |
| GHRS | GH Research PLCordinary shares | $23,643,000 | +5.8% | 1,013,399 | 0.0% | 0.92% | +17.5% | |
| Nuvalent Inc | $23,042,000 | -15.6% | 1,210,192 | 0.0% | 0.90% | -6.1% | ||
| IOVA | Iovance Biotherapeutics Inc | $20,999,000 | -22.6% | 1,100,000 | 0.0% | 0.82% | -13.8% | |
| DAWN | Day One Biopharmaceuticals Inc. | $20,051,000 | -29.0% | 1,189,943 | 0.0% | 0.78% | -21.0% | |
| XENE | Sell | Xenon Pharmaceuticals Inc. | $18,744,000 | +43.1% | 600,000 | -30.0% | 0.73% | +59.3% |
| ALGS | Aligos Therapeutics Inc. | $18,114,000 | -23.5% | 1,526,048 | 0.0% | 0.70% | -14.9% | |
| AKRO | Akero Therapeutics Inc. | $17,586,000 | -5.4% | 831,495 | 0.0% | 0.68% | +5.2% | |
| RARE | New | Ultragenyx Pharmaceutical Inc. | $16,818,000 | – | 200,000 | +100.0% | 0.65% | – |
| CGEM | Cullinan Oncology Inc. | $16,573,000 | -31.6% | 1,074,082 | 0.0% | 0.64% | -24.0% | |
| RAIN | Rain Therapeutics Inc. | $15,134,000 | -13.9% | 1,175,000 | 0.0% | 0.59% | -4.2% | |
| PRTA | Prothena Corporation PLC | $14,820,000 | -30.6% | 300,000 | 0.0% | 0.58% | -22.8% | |
| MIST | Sell | Milestone Pharmaceuticals Inc. | $14,665,000 | -0.1% | 2,238,861 | -13.0% | 0.57% | +11.1% |
| CNTA | Sell | Centessa Pharmaceuticals PLCsponsored ads | $14,088,000 | -36.8% | 1,251,137 | -6.2% | 0.55% | -29.7% |
| PNT | Point Biopharma Global Inc | $14,000,000 | -27.2% | 2,500,000 | 0.0% | 0.54% | -18.9% | |
| BCAB | BioAtla Inc. | $13,473,000 | -33.3% | 686,347 | 0.0% | 0.52% | -25.9% | |
| New | Theseus Pharmaceuticals Inc. | $11,311,000 | – | 892,057 | +100.0% | 0.44% | – | |
| BDTX | Black Diamond Therapeutics Inc. | $10,739,000 | -37.0% | 2,014,858 | 0.0% | 0.42% | -29.9% | |
| SELB | Selecta Biosciences Inc. | $10,706,000 | -21.6% | 3,284,072 | 0.0% | 0.42% | -12.8% | |
| EPIX | Buy | Essa Pharma Inc. | $10,288,000 | +87.2% | 724,500 | +5.5% | 0.40% | +108.3% |
| CDAK | Sell | Codiak Biosciences Inc. | $9,470,000 | -43.7% | 850,065 | -17.5% | 0.37% | -37.3% |
| NGM | NGM Biopharmaceuticals Inc. | $8,855,000 | -15.7% | 500,000 | 0.0% | 0.34% | -6.3% | |
| BMEA | Sell | Biomea Fusion Inc. | $8,854,000 | -64.6% | 1,188,405 | -43.1% | 0.34% | -60.6% |
| MEIP | MEI Pharma Inc. | $7,778,000 | -3.3% | 2,913,091 | 0.0% | 0.30% | +7.5% | |
| New | EQRX Inc. | $6,820,000 | – | 1,000,000 | +100.0% | 0.26% | – | |
| BCEL | Atreca Inc. | $6,673,000 | -51.4% | 2,202,333 | 0.0% | 0.26% | -45.9% | |
| ODT | Sell | Odonate Therapeutics Inc. | $5,680,000 | -65.2% | 4,207,086 | -25.0% | 0.22% | -61.2% |
| SLDB | Sell | Solid Biosciences Inc. | $5,561,000 | -37.7% | 3,177,702 | -14.9% | 0.22% | -30.8% |
| ELEV | Sell | Elevation Oncology Inc. | $5,254,000 | -49.7% | 872,780 | -34.9% | 0.20% | -44.1% |
| RACB | Research Alliance Corp II | $4,885,000 | -0.8% | 500,000 | 0.0% | 0.19% | +10.5% | |
| JYAC | JIYA Acquisition Corp | $4,885,000 | +0.2% | 500,000 | 0.0% | 0.19% | +11.8% | |
| BLSA | BCLS Acquisition Corp | $4,900,000 | -1.6% | 500,000 | 0.0% | 0.19% | +9.2% | |
| PANA | Panacea Acquisition Corp II | $4,850,000 | -0.7% | 500,000 | 0.0% | 0.19% | +9.9% | |
| ACAD | New | Acadia Pharmaceuticals Inc. | $4,318,000 | – | 185,000 | +100.0% | 0.17% | – |
| HSAQ | Health Sciences Acquisition Corp II | $4,032,000 | +1.9% | 400,000 | 0.0% | 0.16% | +13.8% | |
| HLXA | Helix Acquisition Corp | $3,956,000 | -0.6% | 400,000 | 0.0% | 0.15% | +10.8% | |
| GMTX | Gemini Therapeutics Inc. | $3,783,000 | -28.0% | 1,300,000 | 0.0% | 0.15% | -19.7% | |
| DBVT | Sell | DBV Technologies SAsponsored adr | $3,415,000 | -90.8% | 2,134,598 | -71.7% | 0.13% | -89.7% |
| ORIC | Oric Pharmaceuticals Inc. | $2,940,000 | -29.7% | 200,000 | 0.0% | 0.11% | -21.9% | |
| CABA | Sell | Cabaletta Bio Inc. | $2,047,000 | -89.5% | 540,000 | -66.3% | 0.08% | -88.3% |
| OMEG | Omega Alpha SPACcl a | $1,954,000 | +0.4% | 200,000 | 0.0% | 0.08% | +11.8% | |
| TARA | Protara Therapeutics Inc. | $1,412,000 | -2.5% | 209,227 | 0.0% | 0.06% | +7.8% | |
| GNCA | Genocea Biosciences Inc. | $1,316,000 | -39.6% | 1,134,453 | 0.0% | 0.05% | -32.9% | |
| Surrozen Inc | $1,288,000 | -9.0% | 200,000 | 0.0% | 0.05% | +2.0% | ||
| NUVBWS | Nuvation Bio Inc.*w exp 07/07/202 | $504,000 | -26.2% | 266,666 | 0.0% | 0.02% | -16.7% | |
| Exit | MODERNA INCput | $0 | – | -10,000 | -100.0% | -0.01% | – | |
| CLRB | Exit | CELLECTAR BIOSCIENCES INC | $0 | – | -920,000 | -100.0% | -0.03% | – |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -200,000 | -100.0% | -0.07% | – |
| LABD | Exit | DIREXION SHS ETF TRdaily s&p biotec | $0 | – | -150,000 | -100.0% | -0.11% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -290,577 | -100.0% | -0.12% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -890,700 | -100.0% | -0.12% | – |
| NAUT | Exit | NAUTILUS BIOTECHNOLOGY INC | $0 | – | -750,000 | -100.0% | -0.16% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -1,500,000 | -100.0% | -0.18% | – |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -450,000 | -100.0% | -0.25% | – |
| Exit | ERASCA INC | $0 | – | -450,000 | -100.0% | -0.33% | – | |
| IMMP | Exit | IMMUTEP LTDsponsored ads | $0 | – | -2,500,000 | -100.0% | -0.34% | – |
| TLIS | Exit | TALIS BIOMEDICAL CORP | $0 | – | -1,550,998 | -100.0% | -0.34% | – |
| NLTX | Exit | NEOLEUKIN THERAPEUTICS INC | $0 | – | -1,501,058 | -100.0% | -0.38% | – |
| ACHL | Exit | ACHILLES THERAPEUTICS PLCsponsored ads | $0 | – | -1,536,016 | -100.0% | -0.42% | – |
| FSTX | Exit | F-STAR THERAPEUTICS INC | $0 | – | -1,751,428 | -100.0% | -0.45% | – |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -1,675,377 | -100.0% | -0.58% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -1,928,315 | -100.0% | -0.67% | – |
| KURA | Exit | KURA ONCOLOGY INC. | $0 | – | -1,050,289 | -100.0% | -0.69% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -2,400,000 | -100.0% | -0.95% | – | |
| TPTX | Exit | TURNING POINT THERAPEUTICS INC | $0 | – | -525,000 | -100.0% | -1.22% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -1,250,000 | -100.0% | -1.23% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -2,287,782 | -100.0% | -1.53% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -2,081,323 | -100.0% | -1.76% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -170,926 | -100.0% | -1.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
| 13F-HR | 2023-11-14 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.